Skip to content

Solaplus Biotech Co., Ltd.

Active in EUDAMED

Chinafrom EUDAMED address EUDAMED SRN CN-MF-000028411

Devices
1
Registrations
EUDAMED

At a glance

Counted by deviCERTS from registry records

Market reach

European Union
EUDAMED actor

What Solaplus Biotech Co., Ltd. makes

Solaplus Biotech Co., Ltd. manufactures the Hemostatic Xerogel Sponge, a topical agent designed to control bleeding by promoting rapid clotting at wound sites.

The Hemostatic Xerogel Sponge is classified as a Class II device under FDA regulations and is listed in the FDA’s 510(k) registry. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Hemostatic Xerogel Sponge Ref K192671

    Active Regimes: 510(k) Registry: 510(k) Class:—

Company details

EUDAMED SRN
CN-MF-000028411
EUDAMED status
Active
EUDAMED registered name
Solaplus Biotech Co., Ltd.
EUDAMED abbreviated name
Solaplus
Phone
+0577-88597999
PRRC contact
Ningjie Cao(public in EUDAMED)

Frequently asked questions

How many devices does Solaplus Biotech Co., Ltd. have in the registry?

The registry currently lists 1 device for Solaplus Biotech Co., Ltd.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Solaplus Biotech Co., Ltd.'s devices?

Among its 1 most recently registered device, Solaplus Biotech Co., Ltd. has devices listed in FDA 510(k) (1 device).

What are the newest devices from Solaplus Biotech Co., Ltd. in the registry?

The most recently registered devices listed for Solaplus Biotech Co., Ltd. include Hemostatic Xerogel Sponge.

Generated automatically from registry data and not verified by a human reviewer.